Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2002
06/25/2002US6410275 Disposable test devices for performing nucleic acid amplification reactions
06/25/2002US6410274 Plasmid DNA purification using divalent alkaline earth metal ions and two anion exchangers
06/25/2002US6410273 Generating methylated nucleotide sequences; obtain prokaryotc cell, transform with nucleotide sequences and expression vector, culture cells, recover methylated nucleotide sequences
06/25/2002US6410272 Production of thrombin inhibitors
06/25/2002US6410270 Process for the preparation of recombinant proteins in E. coli by high cell density fermentation
06/25/2002US6410269 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
06/25/2002US6410266 Eukaryotic cells for use as tools in genetic engineering
06/25/2002US6410265 Efficient production of p-hydroxybenzoic acid; culture pseudomonas, in the presence toluene, benzoic acid, p-hydroxybenzyl alcohol, p-hydroxybenzaldehyde or p-cresol, recover p-hydroxybenzoic acid
06/25/2002US6410264 Pichia pastoris gene sequences and methods for their use
06/25/2002US6410263 Histidine kinase
06/25/2002US6410262 Secretion factors for gram-positive microorganisms genes encoding them and methods of using it
06/25/2002US6410261 CIITA-interacting proteins and methods of use therefor
06/25/2002US6410259 Fermenting microbial strains
06/25/2002US6410257 Methods to assay gene function with viral vectors
06/25/2002US6410255 Optical probes and assays
06/25/2002US6410253 Cholesterol oxidase
06/25/2002US6410250 Sustained delivery device and methods of making and using the same
06/25/2002US6410249 Odorant receptors
06/25/2002US6410248 General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
06/25/2002US6410245 Complexing; fusion proteins; quantitative analysis
06/25/2002US6410244 Method for preparing plasmids, and uses related thereto
06/25/2002US6410243 Crosslinking; separation
06/25/2002US6410241 Methods of screening open reading frames to determine whether they encode polypeptides with an ability to generate an immune response
06/25/2002US6410240 Complexing
06/25/2002US6410239 Identification and comparison of protein—protein interactions that occur in populations and identification of inhibitors of these interactors
06/25/2002US6410235 Amplification; complexing; separation
06/25/2002US6410233 Isolation and identification of control sequences and genes modulated by transcription factors
06/25/2002US6410230 Detection gene hybridization
06/25/2002US6410229 Expression monitoring by hybridization to high density nucleic acid arrays
06/25/2002US6410228 Method for the identification of synthetic cell- or tissue- specific transcriptional regulatory regions
06/25/2002US6410227 DNA markers for litter size
06/25/2002US6410226 Quantitative analysis; calibration
06/25/2002US6410224 Cleavage of protein using enzyme; therapy for inflammation, asthma, rheumatic diseases, autoimmune diseases
06/25/2002US6410221 Entomopoxvirus expression system
06/25/2002US6410220 Isolation, detection of promoters
06/25/2002US6410057 Biodegradable mixed polymeric micelles for drug delivery
06/25/2002US6410033 Virus comprising foreign dna sequence inserted into genome which is capable of being expressed in infected host cell
06/25/2002US6410032 Attenuated forms of bovine viral diarrhea virus
06/25/2002US6410030 Polypeptide used as immunogenic element carried by peptide sequence between amino acid residues 130 and 230 of sequence of g protein of human respiratory syncytial virus of subgroups a and b, or of bovine respiratory syncytial virus
06/25/2002US6410029 2-methoxyestradiol-induced apoptosis in cancer cells
06/25/2002US6410027 Methods for preparation of vaccines against cancer
06/25/2002US6410026 Preparing rna from isolated cancer cells, making cdna, introducing into host cells, culturing cells to express cancer-derived cdnas, purifying heat shock protein-peptide complexes obtained, administering to treat cancer
06/25/2002US6410023 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
06/25/2002US6410022 Modulation of cholesteryl ester transfer protein (CETP) activity
06/25/2002US6410021 Vaccines of pasteurellaceae mutants and vaccination method
06/25/2002US6410015 Selecting from bone marrow-derived cells population responsive to transforming growth factor beta-1, using as vehicles for transferring genes encoding therapeutic protein to mammal
06/25/2002US6410014 Administering protein-tyrosine kinase chimeras capable of directing cytotoxic t lymphocytes to specifically recognize and lyse target cells
06/25/2002US6410013 Viral vectors for use in monitoring HIV drug resistance
06/25/2002US6410012 Antimicrobial mediated bacterial DNA delivery
06/25/2002US6410011 Treatment of restenosis by gene therapy, comprising the administration of a recombinant adenovirus containing a suicide gene
06/25/2002US6410010 Recombinant P53 adenovirus compositions
06/25/2002US6410008 Chimeric IL-10 proteins and uses thereof
06/25/2002US6409774 Electrophoresis-assisted staining of materials
06/25/2002US6409269 Vehicle seat assembly with thermoformed fibrous suspension panel
06/25/2002CA2245462C Methods of modulating cell proliferation through telomerase modulation
06/25/2002CA2201587C Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
06/25/2002CA2194393C Mammalian telomerase
06/25/2002CA2146712C Cold induced promoter from winter brassica napus
06/25/2002CA2140281C Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis
06/25/2002CA2135648C Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
06/25/2002CA2123612C Hybrid protein between cs from plasmodium and h bsag
06/25/2002CA2095300C Use of genetically modified cells to treat defects, disease or damage of the central nervous system
06/25/2002CA2085881C Dna encoding mammalian phosphodiesterases
06/25/2002CA2081659C Recombinant human factor viii derivatives
06/25/2002CA2036814C Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof
06/25/2002CA2017379C Purification and characterization of a glioma-derived growth factor
06/25/2002CA2006412C Eimeria tenella vaccine
06/23/2002WO2002040654A2 A human serpin secreted from lymphoid cells lsi-01
06/23/2002CA2429179A1 Polynucleotide encoding a novel human serpin secreted from lymphoid cells lsi-01
06/22/2002CA2365791A1 Novel bioluminescent assays and bacterial strains useful therein
06/22/2002CA2365673A1 Methods, compositions and kits relating to cardiovascular disease
06/22/2002CA2365669A1 Methods and reagents for detecting increased risk of developing an inflammatory disorder
06/21/2002CA2326749A1 Nucleic acid encoding ion transporter component protein
06/20/2002WO2002048915A1 Method of detecting relation between genes
06/20/2002WO2002048716A2 Differential phage capture proteomics
06/20/2002WO2002048706A2 Compositions and methods for the synthesis and subsequent modification of uridine-5'-diphosphosulfoquinovose (udp-sq)
06/20/2002WO2002048676A2 Multiple array system for integrating bioarrays
06/20/2002WO2002048405A2 Non-invasive method for detecting target rna
06/20/2002WO2002048404A2 Method and kit for enhancing the association rates of polynucleotides
06/20/2002WO2002048402A2 Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof
06/20/2002WO2002048399A2 Method for the simultaneous dissection in specific positions of filiform organic molecular chains, in particular dna
06/20/2002WO2002048395A1 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states
06/20/2002WO2002048394A1 Infection resistant plants and methods for their generation
06/20/2002WO2002048385A2 Compositions and methods for the release of nucleic acid molecules from solid matrices
06/20/2002WO2002048384A2 Nucleic acid sequence 'm73791' serving as a human gene, and derivatives thereof
06/20/2002WO2002048382A2 Method for the production of a heterologous protein by a fungus
06/20/2002WO2002048380A2 Glycosilated cationic lipids for liposomes used in drug delivery
06/20/2002WO2002048379A1 Expression vector for animal cell containing nuclear matrix attachment region fo interferon beta
06/20/2002WO2002048378A2 Enhancement of freezing tolerance in transgenic plants
06/20/2002WO2002048377A2 Polynucleotide encoding chimeric protein and related vectors, cells, and methods of expression thereof
06/20/2002WO2002048376A2 Bacterial host strains
06/20/2002WO2002048375A2 Purified active hcv ns2/3 protease
06/20/2002WO2002048374A1 A NOVEL POLYPEPTIDE, A HUMAN ss-GLUCOSIDURONATASE 26.29 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
06/20/2002WO2002048373A1 A novel polypeptide, a human mitochondrial methionyl-trna transformylase 41.14 and the polynucleotide encoding the polypeptide
06/20/2002WO2002048372A2 Target enzymes
06/20/2002WO2002048371A1 Stress responsive gene involved in peroxysome biosynthesis
06/20/2002WO2002048370A2 Compositions and methods relating to colon specific genes and proteins
06/20/2002WO2002048369A2 Polynucleotide encoding a human potassium channel beta-subunit, k+mbeta1
06/20/2002WO2002048368A2 Proteins associated with cell growth, differentiation, and death
06/20/2002WO2002048367A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof